DCF — MS BAPTIST MEDICAL CENTER
Enterprise Value: $-686.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-686.5M
Enterprise Value
$-218.3M
PV of Cash Flows
$-468.2M
PV of Terminal Value
$-754.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $462.7M | $-42.2M | -9.0% | $-61.7M | $-56.1M |
| Year 2 | $476.6M | $-38.7M | -8.0% | $-58.8M | $-48.6M |
| Year 3 | $490.9M | $-34.9M | -7.0% | $-55.7M | $-41.8M |
| Year 4 | $505.6M | $-33.4M | -7.0% | $-54.8M | $-37.5M |
| Year 5 | $520.8M | $-33.1M | -6.0% | $-55.2M | $-34.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-686.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$449.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09611058736429576
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5